Healthcare
Live Price
Offline$55.15
+1.87% today
Window Change
+16.89%
Window
May 29, 2026 → Jun 18, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars · May 29, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Travere Therapeutics, Inc. (TVTX) is a Healthcare stock with a market cap of $4.08B and listed on NASDAQ. The stock last traded around $55.15 and up 16.9% across the available one-year price window (May 29, 2026 → Jun 18, 2026). Baseline metrics include revenue growth of +110.5%, EPS growth of +86.3%, a dividend yield of 0.0%. What stands out right now is revenue +110.5%, EPS +86.3%, free cash flow +111.2% with operating margin -12.8% and ROIC -13.9%. Valuation already assumes a fairly strong business story at price/sales 8.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TVTX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TVTX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TVTX Max Drawdown
-8.94%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TVTX and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.